Patents Assigned to University of Antwerp
-
Patent number: 10698065Abstract: An exemplary system, method and computer-accessible medium for removing noise and Gibbs ringing from a magnetic resonance (“MR”) image(s), can be provided, which can include, for example, receiving information related to the MR image(s), receiving information related to the MR image(s), and removing the Gibbs ringing from the information by extrapolating data in a k-space from the MR image(s) beyond an edge(s) of a measured portion of the k-space. The data can be extrapolated by formatting the data as a regularized minimization problem(s). A first weighted term of the regularized minimization problem(s) can preserve a fidelity of the extrapolated data, and a second weighted term of the regularized minimization problem(s) can be a penalty term that can be based a norm(s) of the MR image(s), which can be presumed to be sparse.Type: GrantFiled: May 16, 2016Date of Patent: June 30, 2020Assignees: New York University, University of AntwerpInventors: Dmitry Novikov, Jelle Veraart, Els Fieremans
-
Publication number: 20190017955Abstract: Methods and apparatus for detecting an analyte using fluorinated phthalocyanines is disclosed herein. A method for detecting an analyte includes illuminating an analyte solution which contacts an electrode comprising a conductive material having a photosensitizer coupled thereto to generate a reactive oxygen species, wherein the photosensitizer is a fluorinated pthalocyanine having a metal or a non-metal center, oxidizing an analyte present in the analyte solution with the reactive oxygen species to form an oxidized analyte, and detecting a current resulting from the reduction of the oxidized analyte at the electrode.Type: ApplicationFiled: July 13, 2018Publication date: January 17, 2019Applicants: Seton Hall University, AXES Research Group, Department of Chemistry, University of Antwerp,Inventors: Karolien De Wael, Sergiu M. Gorun, Stanislav Trashin, Erik N. Carrión
-
Patent number: 9901609Abstract: The application relates to medicinal plant extracts and their use in the treatment of diseases, more particularly diseases caused by the presence of stones in ducts of the digestive system.Type: GrantFiled: October 14, 2014Date of Patent: February 27, 2018Assignees: AVICENNA DEVELOPMENT, UNIVERSITY OF ANTWERPInventors: Luc Pieters, Sandra Apers, Mart Theunis, Mark Vaeck, Khalil El Mazouari, Yahia Cherrah
-
Patent number: 9836455Abstract: Classification of collections of items such as words, which are called “document classification,” and more specifically explaining a classification of a document, such as a web-page or website. This can include exemplary procedure, system and/or computer-accessible medium to find explanations, as well as a framework to assess the procedure's performance. An explanation is defined as a set of words (e.g., terms, more generally) such that removing words within this set from the document changes the predicted class from the class of interest. The exemplary procedure system and/or computer-accessible medium can include a classification of web pages as containing adult content, e.g., to allow advertising on safe web pages only. The explanations can be concise and document-specific, and provide insight into the reasons for the classification decisions, into the workings of the classification models, and into the business application itself.Type: GrantFiled: February 23, 2012Date of Patent: December 5, 2017Assignees: NEW YORK UNIVERSITY, UNIVERSITY OF ANTWERPInventors: David Martens, Foster Provost
-
Patent number: 9690749Abstract: A computer-based method for characterizing data dependent on at least one variable is described. The method comprises sampling the data in a smart manner by sampling the data in a finite sequence of sampling points, the finite sequence of sampling points being controlled by a magnifying factor for controlling a spacing between elements of the finite sequence of sampling points and being determined such that function values of functions of a family of functions in said finite sequence of sampling points satisfy a recurrence relation. A corresponding device also is described as well as software-related products.Type: GrantFiled: August 20, 2012Date of Patent: June 27, 2017Assignees: UNIVERSITY OF ANTWERPInventors: Annie Cuyt, Wen-Shin Lee
-
Publication number: 20160213726Abstract: The application relates to medicinal plant extracts and their use in the treatment of diseases, more particularly diseases caused by the presence of stones in ducts of the digestive system.Type: ApplicationFiled: October 14, 2014Publication date: July 28, 2016Applicants: UNIVERSITY OF ANTWERP, AVICENNA DEVELPMENTInventors: Luc Pieters, Sandra Apers, Mart Theunis, Mark Vaeck, Khalil El Mazouari, Yahia Cherrah
-
Publication number: 20140195200Abstract: A computer-based method for characterizing data dependent on at least one variable is described. The method comprises sampling the data in a smart manner by sampling the data in a finite sequence of sampling points, the finite sequence of sampling points being controlled by a magnifying factor for controlling a spacing between elements of the finite sequence of sampling points and being determined such that function values of functions of a family of functions in said finite sequence of sampling points satisfy a recurrence relation. A corresponding device also is described as well as software-related products.Type: ApplicationFiled: August 20, 2012Publication date: July 10, 2014Applicant: UNIVERSITY OF ANTWERPInventors: Annie Cuyt, Wen-Shin Lee
-
Publication number: 20120196300Abstract: The present invention relates to methods for detecting a psychiatric condition optionally associated with a depression comprising the steps of measuring the concentration of at least one in vivo degradation product of tryptophan. Further, the present invention relates to the use of said values as predictive markers for the detection of a psychiatric condition optionally associated with a depression and a kit containing means for detecting said values.Type: ApplicationFiled: February 21, 2012Publication date: August 2, 2012Applicants: DIAMED-EUROGEN N.V., Klinik und Poliklinik fur Psychiatrie und Psychotherapie, UNIVERSITY OF ANTWERP, UNIVERSITY OF MAASTRICHTInventors: Aye Mu Myint, Manfred Schawaller, Robert Verkerk, Markus J. Schwarz, Harald Hampel, Norbert Müller
-
Patent number: 7953249Abstract: This invention provides an improved method for evaluating the quality of images using a test Skr-matrix system. The index k refers to the fractal level in an Skr-matrix, having matrices themselves as elements. The index r?k refers to the Kronecker sub-level to which a typical internal sum structure is present. Skr-matrices can be explained in terms of cognition numbers, basic components, eigenvalues and sine-like eigenvectors. Skr-matrices also form vector spaces in which matrix distances can be properly calculated. The image Skr-quality parameters are derived from an intermediate quasi-Skr-matrix and its best-Skr-approximation in relation to a theoretical reference Skr-matrix. Useful applications are in the field of analogue and digital cameras, scanners, vision sensors, monitors, printers, spectrophotometers, infrared cameras, copying machines, TV-screens, GPS screens, X-rays, Gamma rays, Laser rays, or every other component in the image production and image handling field.Type: GrantFiled: October 4, 2006Date of Patent: May 31, 2011Assignee: University of Antwerp (UIA)Inventor: Luc Mertens
-
Patent number: 7547551Abstract: The present invention provides an improved method for gene delivery in eukaryotic cells by electroporation, preferably in human hematopoietic cells, particular dendritic cells. The method of the invention is superior to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for gene delivery, including tumor antigen loading of dendritic cells.Type: GrantFiled: June 20, 2002Date of Patent: June 16, 2009Assignees: University of Antwerp.Inventors: Gerold Schuler, Zwi N. Berneman, Viggo F. I. Van Tendeloo, Peter Ponsaerts, Isolde Strobel
-
Publication number: 20080200391Abstract: A human ECM-1 polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for stimulating the differentiation in growth of osteoblasts and osteoclasts, which may be used to promote the healing of bone fractures and de novo bone formation, for osteoporosis, for and to promote angiogenesis. Antagonists to the polypeptide of the present invention are also disclosed which may be utilized to treat osteodystrophy, osteohypertrophy, osteoma, osteoblastoma and cancers. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention.Type: ApplicationFiled: April 18, 2008Publication date: August 21, 2008Applicants: HUMAN GENOME SCIENCES, INC., THE UNIVERSITY OF ANTWERPInventors: Jian Ni, Ping Feng, Patrick J. Dillon, Reiner L. Gentz, Joseph Merregaert, Patrick Smits
-
Publication number: 20080131921Abstract: The present invention relates to methods for detecting a psychiatric condition optionally associated with a depression comprising the steps of measuring the concentration of at least one in vivo degradation product of tryptophan. Further, the present invention relates to the use of said values as predictive markers for the detection of a psychiatric condition optionally associated with a depression and a kit containing means for detecting said values.Type: ApplicationFiled: March 30, 2006Publication date: June 5, 2008Applicants: Diamed-Eurogen N. V., University of Maastricht, University of Antwerp, Stiftung fur Diagnostische Forschung, Klinik und Poliklinik fur Psychiatrie und PsychotherapieInventors: Aye Mu Myint, Manfred Schawaller, Robert Verkerk, Markus J. Schwarz, Harald Hampel, Norbert Muller
-
Patent number: 7199225Abstract: A human ECM-1 polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for stimulating the differentiation in growth of osteoblasts and osteoclasts, which may be used to promote the healing of bone fractures and de novo bone formation, for osteoporosis, for and to promote angiogenesis. Antagonists to the polypeptide of the present invention are also disclosed which may be utilized to treat osteodystrophy, osteohypertrophy, osteoma, osteoblastoma and cancers. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention.Type: GrantFiled: May 12, 2003Date of Patent: April 3, 2007Assignees: Human Genome Sciences, Inc., University of AntwerpInventors: Jian Ni, Ping Feng, Patrick J. Dillon, Reiner L. Gentz, Joseph Merregaert, Patrick Smits
-
Patent number: 7071312Abstract: A human epidermal differentiation factor polypeptide and DNA (RNA) encoding such polypeptide and procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for treating and/or preventing skin diseases. Diagnostic assays for detecting mutations in a nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.Type: GrantFiled: August 11, 2004Date of Patent: July 4, 2006Assignees: The University of Antwerp, Human Genome Sciences, Inc.Inventors: Jian Ni, Ping Feng, Patrick J. Dillon, Reiner L. Gentz, Joseph Merregaert, Patrick Smits
-
Publication number: 20060063922Abstract: A human epidermal differentiation factor polypeptide and DNA (RNA) encoding such polypeptide and procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for treating and/or preventing skin diseases. Diagnostic assays for detecting mutations in a nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.Type: ApplicationFiled: November 8, 2005Publication date: March 23, 2006Applicants: The University of Antwerp, Human Genome Sciences, Inc.Inventors: Jian Ni, Ping Feng, Patrick Dillon, Reiner Gentz, Joseph Merregaert, Patrick Smits
-
Publication number: 20050227282Abstract: A human ECM-1 polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for stimulating the differentiation in growth of osteoblasts and osteoclasts, which may be used to promote the healing of bone fractures and de novo bone formation, for osteoporosis, for and to promote angiogenesis. Antagonists to the polypeptide of the present invention are also disclosed which may be utilized to treat osteodystrophy, osteohypertrophy, osteoma, osteoblastoma and cancers. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention.Type: ApplicationFiled: June 2, 2005Publication date: October 13, 2005Applicants: Human Genome Sciences, Inc., The University of AntwerpInventors: Jian Ni, Ping Feng, Patrick Dillon, Reiner Gentz, Joseph Merregaert, Patrick Smits
-
Publication number: 20050009141Abstract: A human epidermal differentiation factor polypeptide and DNA (RNA) encoding such polypeptide and procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for treating and/or preventing skin diseases. Diagnostic assays for detecting mutations in a nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.Type: ApplicationFiled: August 11, 2004Publication date: January 13, 2005Applicants: The University of Antwerp, Human Genome Sciences, Inc.Inventors: Jian Ni, Ping Feng, Patrick Dillon, Reiner Gentz, Joseph Merregaert, Patrick Smits
-
Publication number: 20040110677Abstract: A human ECM-1 polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for stimulating the differentiation in growth of osteoblasts and osteoclasts, which may be used to promote the healing of bone fractures and de novo bone formation, for osteoporosis, for and to promote angiogenesis. Antagonists to the polypeptide of the present invention are also disclosed which may be utilized to treat osteodystrophy, osteohypertrophy, osteoma, osteoblastoma and cancers. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention.Type: ApplicationFiled: May 12, 2003Publication date: June 10, 2004Applicants: Human Genome Sciences, Inc., University of AntwerpInventors: Jian Ni, Ping Feng, Patrick J. Dillon, Reiner L. Gentz, Joseph Merregaert, Patrick Smits
-
Patent number: 6730475Abstract: The invention features methods of diagnosing and treating Meniere disease. The invention also features kits and probes for diagnosing Meniere disease.Type: GrantFiled: May 25, 2000Date of Patent: May 4, 2004Assignees: Brigham and Women's Hospital, University of AntwerpInventors: Nahid Robertson, Cynthia Morton, Guy Van Camp, Erik Fransen, Paul Van de Heyning